THE ROLE OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN OF TYPE 9 (PCSK-9) IN CHOLESTEROL METABOLISM AND NEW OPPORTUNITIES OF LIPID CORRECTIVE THERAPYстатьяИсследовательская статья
Дата последнего поиска статьи во внешних источниках: 29 июля 2020 г.
Аннотация:Proprotein-convertase subtilisin/kexin of type 9 (PCSK-9) is an essential enzyme that regulates the circulating levels of low-density lipoprotein (LDL), due to its central role in the destruction of low-density lipoprotein receptors (RLPN) located on the surface of hepatocytes. The literature review examines the key studies that allowed us to establish the mechanism of action of PCSK-9, which has led to the development of a new class of lipid-lowering drugs – PCSK-9 inhibitors